Krsnaa Diagnostics
Ticker > Company >

Krsnaa Diagnostics share price

Krsnaa Diagnostics Ltd.

NSE: KRSNAA BSE: 543328 SECTOR: Hospital & Healthcare Services  1.35 L   236   60

844.90
+8.85 (1.06%)
NSE: Today, 11:14 AM

Price Summary

Today's High

₹ 849

Today's Low

₹ 832

52 Week High

₹ 1044

52 Week Low

₹ 625.75

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2740.74 Cr.

Enterprise Value

₹ 2874.45 Cr.

No. of Shares

3.24 Cr.

P/E

32.55

P/B

3.02

Face Value

₹ 5

Div. Yield

0.33 %

Book Value (TTM)

₹  279.45

CASH

₹ 67.91 Cr.

DEBT

₹ 201.62 Cr.

Promoter Holding

27.11 %

EPS (TTM)

₹  25.95

Sales Growth

15.54%

ROE

9.74 %

ROCE

12.96%

Profit Growth

41.4 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.54%
3 Year14.44%
5 Year21.41%

Profit Growth

1 Year41.4%
3 Year5.41%
5 Year22.33%

ROE%

1 Year9.74%
3 Year8.73%
5 Year9.44%

ROCE %

1 Year12.96%
3 Year11.68%
5 Year36.45%

Debt/Equity

0.2273

Price to Cash Flow

30.66

Interest Cover Ratio

5.4615

CFO/PAT (5 Yr. Avg.)

0.948135875147391

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 27.11 0.00
Mar 2025 27.24 0.00
Dec 2024 27.24 0.00
Sep 2024 27.17 0.00
Jun 2024 27.17 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The Company has been maintaining an effective average operating margins of 26.7267477247799% in the last 5 years.
  • Company’s PEG ratio is 0.786276495276528.
  • The company has an efficient Cash Conversion Cycle of -44.9923 days.

 Limitations

  • The company has shown a poor profit growth of 5.40911116650953% for the Past 3 years.
  • The company has shown a poor revenue growth of 14.4354690441816% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 163.16 178.72 165.16 174.65 175.62
Total Expenditure 120.18 126.24 117.26 121.35 125.52
Operating Profit 42.98 52.48 47.89 53.31 50.1
Other Income 7.32 4.6 9.29 4.46 4
Interest 5.3 6.39 6.13 6.75 6.25
Depreciation 21.47 22.2 22.69 21.8 21.51
Exceptional Items 0 0 0 0 0
Profit Before Tax 23.53 28.5 28.37 29.21 26.34
Tax 5.35 6.53 6.77 8.15 6.78
Profit After Tax 18.18 21.97 21.6 21.07 19.56
Adjusted EPS (Rs) 5.63 6.8 6.69 6.52 6.03

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 396.46 454.89 464.08 590.02 681.7
Total Expenditure 302.65 320.34 339.84 443.86 485.04
Operating Profit 93.81 134.55 124.25 146.16 196.66
Other Income 265.02 14.93 19.41 16.8 25.67
Interest 25.94 18.49 7.68 16.47 24.57
Depreciation 37.44 41.39 53.78 74.55 88.16
Exceptional Items 0 0 0 0 0
Profit Before Tax 295.45 89.6 82.19 71.95 109.6
Tax 110.52 18.9 18.68 13.38 26.79
Net Profit 184.93 70.7 63.51 58.56 82.81
Adjusted EPS (Rs.) 142.36 22.52 20.23 18.14 25.65

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 248.89 15.7 15.7 16.15 16.15
Total Reserves -17.02 671.05 726.8 799.1 877.15
Borrowings 167.95 33.07 24.28 41.88 45.48
Other N/C liabilities 20.91 37.59 47.35 38.39 45.31
Current liabilities 188.55 119.64 95.25 276.05 299.23
Total Liabilities 609.28 877.06 909.38 1171.57 1283.31
Assets
Net Block 308.51 385.69 470.68 647.16 667.68
Capital WIP 3.72 28.26 25.48 9.85 2.96
Intangible WIP 0 0 0 0 0
Investments 0.29 0.36 0.36 0.36 31.62
Loans & Advances 33.83 17.87 26.37 62.37 48.3
Other N/C Assets 10.04 109.11 162.75 29.43 113.59
Current Assets 252.89 335.77 223.75 422.41 419.16
Total Assets 609.28 877.06 909.38 1171.57 1283.31
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 295.45 89.6 82.19 71.95 109.6
Adjustment -198.74 49.2 44.79 69.9 97.63
Changes in Assets & Liabilities 29.62 -3.46 -38.37 -98.65 -98.16
Tax Paid -7.67 -6.63 -13.13 -18.8 -19.69
Operating Cash Flow 118.66 128.71 75.48 24.39 89.38
Investing Cash Flow -67.37 -241.1 -108.54 -128.88 -101.83
Financing Cash Flow 20.03 176.04 -33.13 84.21 13.91
Net Cash Flow 71.32 63.65 -66.19 -20.27 1.46

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 27.17 27.17 27.24 27.24 27.11
krsna diagnostics (mumbai... 2.30 2.30 2.37 2.37 2.36
rajendra khivraj mutha 24.87 24.87 24.87 24.87 24.75
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 72.83 72.83 72.76 72.76 72.89
bandhan bse healthcare in... - 1.34 1.25 1.32 1.63
hdfc life insurance compa... 2.06 2.06 2.06 2.06 2.05
k india opportunities fun... 2.19 2.19 2.19 2.19 2.18
kirankumar prabhakar bhis... 1.57 1.20 1.23 1.10 1.10
phi capital trust - phi c... 15.44 15.44 15.44 15.44 15.37
tata mutual fund - tata s... 7.73 7.73 7.73 7.73 7.69
icici prudential pharma h... 2.73 2.15 - - -
bandhan small cap fund 1.33 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit ICRA
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY23
Concall Q3FY22
Concall Q2FY22
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY23
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY22

Company News

Krsnaa Diagnostics informs about analyst meet 10 Sep, 2:51 PM Krsnaa Diagnostics informs about newspaper advertisement 13 Aug, 12:03 PM Krsnaa Diagnostics - Quaterly Results 11 Aug, 7:15 PM Krsnaa Diagnostics - Quaterly Results 11 Aug, 7:15 PM Krsnaa Diagnostics informs about analyst meet 26 Jun, 12:37 PM Krsnaa Diagnostics - Quaterly Results 12 May, 7:20 PM Krsnaa Diagnostics - Quaterly Results 12 May, 7:20 PM Krsnaa Diagnostics informs about analyst meet 22 Mar, 3:11 PM Krsnaa Diagnostics informs about press release 12 Mar, 3:15 PM Krsnaa Diagnostics informs about notice of postal ballot 11 Mar, 5:02 PM Krsnaa Diagnostics informs about earnings call transcript 20 Feb, 6:21 PM Krsnaa Diagnostics informs about press release 14 Feb, 2:45 PM Krsnaa Diagnostics informs about outcome of board meeting 12 Feb, 5:25 PM Krsnaa Diagnostics - Quaterly Results 12 Feb, 3:18 PM Krsnaa Diagnostics - Quaterly Results 12 Feb, 3:18 PM Krsnaa Diagnostics - Quaterly Results 12 Feb, 3:18 PM Krsnaa Diagnostics informs about analyst meet 15 Jan, 1:09 PM Krsnaa Diagnostics informs about analyst meet 6 Jan, 3:41 PM Krsnaa Diagnostics informs about disclosure 3 Jan, 5:22 PM Krsnaa Diagnostics informs about analyst meet 1 Jan, 2:43 PM Krsnaa Diagnostics informs about trading window closure 23 Dec, 12:26 PM Krsnaa Diagnostics informs about analyst meet 6 Nov, 12:52 PM Krsnaa Diagnostics - Quaterly Results 25 Oct, 8:29 PM Krsnaa Diagnostics - Quaterly Results 25 Oct, 8:29 PM Krsnaa Diagnostics to expand Radiology services, Pathology laboratory services in Ranchi 11 Oct, 10:22 AM Krsnaa Diagnostics informs about analyst meet 8 Oct, 4:56 PM Krsnaa Diagnostics enters into strategic partnership with Medikabazaar 1 Oct, 2:40 PM Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare 26 Sep, 4:51 PM Krsnaa Diagnostics submits analyst meet intimation 27 Aug, 12:44 PM Krsnaa Diagnostics informs about newspaper publication 24 Aug, 2:46 PM Krsnaa Diagnostics informs about newspaper publication 8 Aug, 1:14 PM Krsnaa Diagnostics - Quaterly Results 6 Aug, 7:13 PM Krsnaa Diagnostics - Quaterly Results 6 Aug, 7:13 PM Krsnaa Diagnostics gets tender from Bhabha Atomic Research Centre 5 Jul, 10:58 AM Krsnaa Diagnostics informs about closure of trading window 22 Jun, 3:53 PM Krsnaa Diagnostics - Quaterly Results 18 May, 7:35 PM Krsnaa Diagnostics - Quaterly Results 18 May, 7:35 PM Krsnaa Diagnostics inks pact with Government of Maharashtra 2 May, 3:29 PM Krsnaa Diagnostics incorporates wholly owned subsidiary 9 Apr, 3:26 PM Krsnaa Diagnostics informs about newspaper publication 6 Mar, 12:33 PM Krsnaa Diagnostics informs about analyst meet 5 Mar, 5:30 PM Krsnaa Diagnostics informs about notice of postal ballot 5 Mar, 12:31 PM Krsnaa Diagnostics informs about investors meet 23 Feb, 2:43 PM Krsnaa Diagnostics submits analyst meet intimation 23 Feb, 12:32 PM Krsnaa Diagnostics informs about analyst meet 20 Feb, 3:27 PM Krsnaa Diagnostics informs about resignation of managing director 13 Feb, 10:02 AM Krsnaa Diagnostics informs about grant of options under ESOS 13 Feb, 9:56 AM Krsnaa Diagnostics informs about incorporation of WOS 13 Feb, 9:55 AM Krsnaa Diagnostics gets nod to incorporate wholly owned subsidiary 13 Feb, 9:48 AM Krsnaa Diagnostics - Quaterly Results 12 Feb, 10:01 PM

Krsnaa Diagnostics Stock Price Analysis and Quick Research Report. Is Krsnaa Diagnostics an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Krsnaa Diagnostics. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Krsnaa Diagnostics has a PE ratio of 32.249115750052 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Krsnaa Diagnostics has ROA of 6.7464% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Krsnaa Diagnostics has a Current ratio of 1.4008.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Krsnaa Diagnostics has a ROE of 9.7438%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Krsnaa Diagnostics has a Debt to Equity ratio of 0.2273 which means that the company has low proportion of debt in its capital.

  • Sales growth: Krsnaa Diagnostics has reported revenue growth of 15.5378% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Krsnaa Diagnostics for the current financial year is 28.8482385817704%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Krsnaa Diagnostics is Rs 2.75 and the yield is 0.3293%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Krsnaa Diagnostics is Rs 25.9542. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Krsnaa Diagnostics in Ticker for free. Also, one can get the intrinsic value of Krsnaa Diagnostics by using Valuation Calculators, which are available with a Finology ONE subscription. 

Krsnaa Diagnostics FAQs

Q1. What is Krsnaa Diagnostics share price today?
Ans: The current share price of Krsnaa Diagnostics is Rs 837.

Q2. What is the market capitalisation of Krsnaa Diagnostics?
Ans: Krsnaa Diagnostics has a market capitalisation of Rs 2715.1168464 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Krsnaa Diagnostics?
Ans: The PE ratio of Krsnaa Diagnostics is 32.249115750052 and the P/B ratio of Krsnaa Diagnostics is 2.99517658480447, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Krsnaa Diagnostics share?
Ans: The 52-week high share price of Krsnaa Diagnostics is Rs 1044, and the 52-week low share price of Krsnaa Diagnostics is Rs 625.75.

Q5. Does Krsnaa Diagnostics pay dividends?
Ans: Currently, Krsnaa Diagnostics pays dividends. Dividend yield of Krsnaa Diagnostics is around 0.3293%.

Q6. What are the face value and book value of Krsnaa Diagnostics shares?
Ans: The face value of Krsnaa Diagnostics shares is Rs 5, while the book value per share of Krsnaa Diagnostics is around Rs 279.4493. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Krsnaa Diagnostics?
Ans: Krsnaa Diagnostics has a total debt of Rs 201.617 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Krsnaa Diagnostics?
Ans: The ROE of Krsnaa Diagnostics is 9.7438% and ROCE of Krsnaa Diagnostics is 12.9634%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Krsnaa Diagnostics a good buy for the long term?
Ans: The Krsnaa Diagnostics long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Krsnaa Diagnostics undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Krsnaa Diagnostics appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Krsnaa Diagnostics’s financials?
Ans: You can review Krsnaa Diagnostics’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Krsnaa Diagnostics

Krsnaa Diagnostics Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Krsnaa Diagnostics Ltd. is a leading diagnostics service provider in India. With a strong presence in both urban and rural areas, the company is committed to providing high-quality diagnostic services to its customers. Krsnaa Diagnostics offers a wide range of diagnostic services including pathology, radiology, imaging, and tele-radiology services.

The company has a well-established network of diagnostic centers and offers its services through a hub-and-spoke model, allowing it to reach a larger customer base. Krsnaa Diagnostics is known for its state-of-the-art infrastructure, advanced technology, and highly skilled professionals.

Krsnaa Diagnostics Ltd. - Share Price

Investors interested in Krsnaa Diagnostics Ltd. can keep track of its share price on our website. We provide real-time updates on the stock's performance, allowing investors to make informed decisions. Our website also offers pre-built screening tools that enable investors to analyze the company's share price over different time periods and compare it to industry peers.

Krsnaa Diagnostics Ltd. - Balance Sheet

The balance sheet of Krsnaa Diagnostics Ltd. provides a snapshot of the company's financial position. Investors can access the company's annual reports on our website, which include detailed information about its assets, liabilities, and shareholders' equity. For a comprehensive analysis, our premium features allow fair value calculation through tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Krsnaa Diagnostics Ltd. - Annual Report

Krsnaa Diagnostics Ltd. releases its annual reports on our website, which provide a comprehensive overview of the company's performance throughout the year. These reports include valuable information about the company's financial statements, business operations, growth prospects, and future plans. Investors can download these reports to gain insights and make informed investment decisions.

Krsnaa Diagnostics Ltd. - Dividend

Investors interested in dividends can find information about Krsnaa Diagnostics Ltd.'s dividend payments on our website. We provide updates on the company's dividend history, including the amount paid and the dividend yield. Investors can use this information to assess the company's dividend policy and evaluate its potential as an income-generating investment.

Krsnaa Diagnostics Ltd. - Quarterly Result

Tracking Krsnaa Diagnostics Ltd.'s quarterly results is essential for investors. Our website offers quarterly result updates, allowing investors to stay informed about the company's financial performance and analyze trends over time. Our premium features enable investors to conduct in-depth analysis and calculate the fair value of the stock using various tools.

Krsnaa Diagnostics Ltd. - Stock Price

Our website provides real-time updates on Krsnaa Diagnostics Ltd.'s stock price. Investors can track the stock's performance and view price charts to identify patterns or trends. We also offer pre-built screening tools to analyze the stock price and compare it to industry peers, helping investors make informed investment decisions.

Krsnaa Diagnostics Ltd. - Price Chart

Monitoring the price chart of Krsnaa Diagnostics Ltd.'s stock is crucial for investors. Our website offers interactive price charts that provide a visual representation of the stock's performance over different time periods. Investors can use these charts to identify historical price patterns and make predictions about future price movements.

Krsnaa Diagnostics Ltd. - News

Stay updated with the latest news about Krsnaa Diagnostics Ltd. on our website. We provide timely news updates related to the company's business operations, financial performance, strategic partnerships, and other relevant events. Investors can access these news articles to stay informed and make well-informed investment decisions.

Krsnaa Diagnostics Ltd. - Concall Transcripts

Investors interested in gaining insights from Krsnaa Diagnostics Ltd.'s investor conference calls can access the transcripts on our website. These transcripts provide a verbatim record of the discussions and presentations during the conference calls. Investors can refer to these transcripts for detailed information about the company's strategy, financial performance, and future outlook.

Krsnaa Diagnostics Ltd. - Investor Presentations

Krsnaa Diagnostics Ltd. provides investor presentations on our website. These presentations offer valuable insights into the company's business model, growth prospects, and financial performance. Investors can download these presentations to gain a deeper understanding of the company and make informed investment decisions.

Krsnaa Diagnostics Ltd. - Promoters

Krsnaa Diagnostics Ltd. has a dedicated team of promoters who have played a vital role in the company's growth and success. Our website provides information about the promoters, their backgrounds, and their contributions to the company. Knowing about the promoters can help investors gauge the company's leadership and their commitment to long-term growth.

Krsnaa Diagnostics Ltd. - Shareholders

Understanding the company's shareholders is crucial for investors. Our website provides information about Krsnaa Diagnostics Ltd.'s major shareholders, including institutional investors and individual investors. Investors can analyze the shareholding pattern to assess the confidence of other investors in the company and make informed investment decisions.

Remember, you can find additional tools and resources on our website, such as annual reports, concall transcripts, investor presentations, credit ratings, and research reports, to support your stock analysis. We aim to provide comprehensive information and analysis that will be valuable to long-term stock investors. 

Krsnaa Diagnostics Balance Sheet Overview

Analyzing the balance sheet of Krsnaa Diagnostics reveals significant insights into the company's financial health over the years from March 2020 to March 2024.

Krsnaa Diagnostics Equity and Liabilities

Starting with the equity and liabilities section, Share Capital saw an interesting fluctuation, peaking at Rs 248.89 Cr. in March 2021 but eventually stabilizing to Rs 16.15 Cr. by March 2024. Total Reserves experienced a dramatic turnaround from a negative Rs 217.16 Cr. in March 2020 to a robust Rs 799.10 Cr. by March 2024. Borrowings and Other Non-current Liabilities have seen varying trends but remained managed, ensuring the company's leverage is in check.

Krsnaa Diagnostics Assets Analysis

On the assets front, the Net Block and Current Assets have shown an appreciable increase, indicating investment in the company's operational capacities and liquidity. Specifically, the Net Block surged to Rs 647.16 Cr., showing a strong investment in long-term assets. The fluctuation in Current Assets, peaking at Rs 422.41 Cr. in March 2024, signals an improvement in the company's ability to cover short-term obligations.

Key Financial Metrics

The Total Liabilities and Total Assets both escalated to Rs 1,171.57 Cr., demonstrating a balanced growth in Krsnaa Diagnostics' financial structure. The increase in Total Reserves and a manageable level of borrowings reflect a solid financial foundation poised for future growth.

This analysis is based on the Standalone Balance Sheet of the company, offering insights invaluable to investors looking into the health sector stocks within the NSE BSE indices.

Understand the trends, keep an eye on sectors showing promising growth.

Read More
X